{"actinic keratosis": 109.32, "acute kidney injury": 2.37, "acute respiratory distress syndrome": 4.41, "agitation": 3.36, "agranulocytosis": 2.89, "alanine aminotransferase increased": 4.37, "altered state of consciousness": 3.44, "aspartate aminotransferase increased": 3.56, "aspergillus infection": 62.5, "blood alkaline phosphatase increased": 10.9, "blood bilirubin increased": 2.86, "blood creatinine increased": 2.18, "blood potassium decreased": 2.32, "bone disorder": 3.46, "brain abscess": 24.61, "bronchopulmonary aspergillosis": 49.66, "candida infection": 7.98, "chloropsia": 187.39, "cholestasis": 17.99, "chromatopsia": 44.77, "condition aggravated": 3.47, "confusional state": 2.67, "delirium": 16.5, "dermatitis bullous": 4.6, "disease progression": 2.35, "disorganised speech": 82.89, "drug ineffective": 5.28, "drug ineffective for unapproved indication": 19.39, "drug interaction": 14.06, "drug intolerance": 3.41, "drug level above therapeutic": 74.85, "drug level below therapeutic": 73.6, "drug level decreased": 38.99, "drug level increased": 41.95, "drug reaction with eosinophilia and systemic symptoms": 3.07, "drug resistance": 20.0, "drug-induced liver injury": 32.43, "dyschromatopsia": 36.64, "dysphoria": 2.9, "electrocardiogram qt prolonged": 11.32, "electrolyte imbalance": 5.66, "encephalopathy": 4.3, "eye disorder": 4.26, "fluoride increased": 1236.86, "fluorosis": 1999.2, "fungal infection": 9.36, "fusarium infection": 91.69, "gamma-glutamyltransferase increased": 6.87, "haemoptysis": 2.69, "hallucination": 35.59, "hallucination, auditory": 20.75, "hallucination, visual": 80.74, "hallucinations, mixed": 22.32, "halo vision": 89.28, "hepatic cytolysis": 7.24, "hepatic enzyme increased": 8.76, "hepatic failure": 3.26, "hepatic function abnormal": 17.33, "hepatitis": 3.34, "hepatitis cholestatic": 13.24, "hepatotoxicity": 33.76, "hyperbilirubinaemia": 2.62, "hypercalcaemia": 7.16, "hypertransaminasaemia": 6.83, "hypertrophic osteoarthropathy": 749.8, "hypokalaemia": 6.53, "hyponatraemia": 3.8, "immunosuppressant drug level increased": 18.5, "initial insomnia": 5.17, "jaundice": 2.11, "liver disorder": 3.12, "liver function test abnormal": 7.5, "liver function test increased": 4.18, "liver injury": 28.66, "mental disorder": 11.17, "mental status changes": 3.01, "mucormycosis": 82.63, "multiple organ dysfunction syndrome": 5.68, "musculoskeletal pain": 2.45, "nephropathy toxic": 6.04, "nervous system disorder": 6.09, "neuropathy peripheral": 2.23, "neurotoxicity": 14.32, "off label use": 3.11, "pathogen resistance": 22.87, "periostitis": 2423.66, "photodermatosis": 187.83, "photophobia": 2.08, "photopsia": 5.91, "photosensitivity reaction": 57.98, "pneumonia fungal": 16.68, "polyneuropathy": 2.54, "product use in unapproved indication": 2.98, "pseudoporphyria": 706.98, "pulmonary mass": 3.61, "renal impairment": 3.15, "respiratory failure": 4.08, "restlessness": 2.27, "rhabdomyolysis": 5.0, "scedosporium infection": 73.67, "septic shock": 3.37, "skin disorder": 3.35, "skin lesion": 4.21, "squamous cell carcinoma": 32.61, "squamous cell carcinoma of skin": 98.56, "stevens-johnson syndrome": 2.0, "systemic candida": 23.44, "therapeutic product effect incomplete": 2.95, "therapeutic response decreased": 3.17, "therapy non-responder": 2.39, "torsade de pointes": 22.38, "toxic epidermal necrolysis": 9.7, "toxic optic neuropathy": 208.03, "toxicity to various agents": 3.74, "transaminases increased": 4.97, "treatment failure": 9.48, "ventricular tachycardia": 3.03, "vision blurred": 3.97, "visual impairment": 4.55, "vitreous floaters": 3.92, "xanthopsia": 101.9}